arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

InflaRx N.V.

IFRX Health Care Biotechnology: Pharmaceutical Preparations
$1.56
▲ +0.7% Today
as of Oct 23, 16:49 ET
Last 30 days -26.42% Sep 14 → Oct 23
$1.26 $1.49 $1.72 $1.95 $2.18 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.51
High
$1.58
Low
$1.48
Volume
$889,582
Avg Vol
$2M
Mkt Cap
$252M
P/E (TTM)
—
Beta
—
52w High
$2.95
52w Low
$0.80
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 5 items

Oct 22 · 16:00 PR GlobeNewswire
InflaRx Highlights Izicopan’s Therapeutic Potential at Kidney Week 2026
Oct 2 · 11:30 PR GlobeNewswire
InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
Oct 1 · 11:30 PR GlobeNewswire
InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
▸ Show all 5 press releases & news Free account →

IFRX earnings at a glance

The options market is pricing a move of about ±62.1% after the report, a range of roughly $0.59 to $2.53 from today's $1.56. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±17.2% on average; after the most recent report on May 6, 2026 it moved +26.9%. That means options currently expect more movement than IFRX has typically delivered. IFRX beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 471%. The share price of $1.56 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.80
$2.95
35% of range
Avg surprise (last 4)
+17.3%
Avg reaction (last 2)
+9.7%
50% positive
Latest IV / EM
471%
EM ±62.1% · $2 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.24$-0.20$-0.16$-0.13$-0.09 Actual $-0.14Est $-0.18Actual $-0.24Est $-0.24Actual $-0.16Est $-0.16Actual $-0.09Est $-0.17 Mar/2025Jun/2025Sep/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-0.09 $-0.17 +47.1% +35.7% +26.9% earnings
Mon Nov 10, 2025Sep/2025 $-0.16 $-0.16 0.0% — — earnings
Thu Aug 7, 2025Jun/2025 $-0.24 $-0.24 0.0% — — earnings
Wed May 7, 2025Mar/2025 $-0.14 $-0.18 +22.2% — -7.5% earnings

Implied volatility — last 90 days

64%169%275%380%485% Jun 08 — IV 465% · EM ±61.4%Jun 09 — IV 486% · EM ±60.8%Jun 19 — IV 138% · EM ±30.4%Jun 22 — IV 146% · EM ±30.4%Jun 23 — IV 266% · EM ±54.4%Jun 24 — IV 65% · EM ±13.0%Jun 25 — IV 66% · EM ±13.0%Jun 30 — IV 233% · EM ±40.2%Jul 01 — IV 141% · EM ±23.6%Jul 02 — IV 146% · EM ±23.6%Jul 10 — IV 450% · EM ±49.8%Jul 13 — IV 407% · EM ±34.0%Jul 14 — IV 470% · EM ±34.0%Jul 20 — IV 105% · EM ±24.7%Jul 21 — IV 113% · EM ±26.2%Jul 22 — IV 86% · EM ±19.8%Jul 23 — IV 283% · EM ±63.6%Jul 27 — IV 310% · EM ±64.7%Aug 04 — IV 277% · EM ±47.8%Aug 05 — IV 372% · EM ±62.1%Aug 06 — IV 395% · EM ±64.0%Aug 07 — IV 393% · EM ±61.4%Aug 12 — IV 99% · EM ±12.4%Aug 13 — IV 103% · EM ±12.2%Aug 14 — IV 89% · EM ±9.8%Aug 17 — IV 116% · EM ±9.7%Aug 18 — IV 190% · EM ±13.8%Aug 19 — IV 240% · EM ±14.2%Aug 20 — IV 340% · EM ±14.2%Aug 26 — IV 77% · EM ±15.5%Aug 27 — IV 79% · EM ±15.5%Aug 28 — IV 223% · EM ±42.6%Sep 02 — IV 219% · EM ±36.6%Sep 03 — IV 263% · EM ±42.6%Sep 16 — IV 373% · EM ±22.1%Sep 21 — IV 192% · EM ±40.1%Oct 02 — IV 302% · EM ±47.2%Oct 06 — IV 471% · EM ±62.1%

Sector peers

AMRN
Amarin Corporation plc
$254M $11.79+2.4%
QTTB
Q32 Bio Inc.
$246M $8.65-0.2%
BCYC
Bicycle Therapeutics plc
$261M $3.55-0.6%
AKBA
Akebia Therapeutics, Inc.
$241M $0.57-3.1%
SLGL
Sol-Gel Technologies Ltd.
$238M $69.45+5.7%
SIGA
SIGA Technologies Inc.
$234M $3.120.0%

IFRX earnings FAQ

What is IFRX's expected move for earnings?

Options currently price a move of about ±62.1%, or $0.97 per share either way from $1.56.

How does IFRX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±17.2%, up 1 times and down 1 times.

What is IFRX's implied volatility?

IFRX's at-the-money implied volatility is about 471% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in